Hubei Cangsheng Trading Co., Ltd.   is a professional crude drug manufacturer which integrates production, R&D and sales. The technology ability is strong. is a quality China supplier of steroids raw powder, anabolics body’building materials, fitness supplement hormones, muscle gain raw steroids, weight loss raw powder,anti-estrogen hormones powder, and peptides.

we serve over 50 countries' customers with high reputation, high quality, reasonable price, and safe shipping are our keys to serve the customers to establish a long-term and stable cooperation relationship with customers in the world.

We have bridle-wise manage team, research team and QC team, strictly controthe mass production quality.
Our products quality and quantity very stable also our price is competitive.    

Teriparatide, also known as Teriparatide, is a synthetic parathyroid hormone polypeptide. It is also a 34-amino acid polypeptide that promotes bone formation and prevents osteoporosis. It can regulate bone metabolism, stimulate the activity of osteoblasts, and increase calcium deposition.

It is mainly used for the treatment of osteoporosis. Mechanism of action: It is a synthetic parathyroid hormone fragment that mainly promotes bone growth by activating osteoblasts. Unlike traditional anti-osteoporosis drugs, teriparatide can not only inhibit bone resorption but also stimulate bone formation.

When parathyroid hormone (PTH) is administered once daily, teriparatide can preferentially stimulate the activity of osteoblasts rather than that of osteoclasts, thereby stimulating the formation of new bone on the surface of trabecular and cortical bones, increasing bone mass, improving the microstructure of bones, enhancing bone strength, and reducing the risk of fractures.

Indications: It is mainly used for the treatment of osteoporosis in postmenopausal women and in men and women who have received long-term corticosteroid therapy. It is suitable for patients who have already suffered fractures or are at risk of fractures, especially those over 50 years old. It is also applicable to patients with other types of osteoporosis, including those with an increased risk of fractures due to osteoporosis.